» Articles » PMID: 34987549

Systematic Analysis of MRNAs and NcRNAs in BMSCs of Senile Osteoporosis Patients

Overview
Journal Front Genet
Date 2022 Jan 6
PMID 34987549
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Senile osteoporosis (SOP) is a worldwide age-related disease characterized by the loss of bone mass and decrease in bone strength. Bone mesenchymal stem cells (BMSCs) play an important role in the pathology of senile osteoporosis. Abnormal expression and regulation of non-coding RNA (ncRNA) are involved in a variety of human diseases. In the present study, we aimed to identify differentially expressed mRNAs and ncRNAs in senile osteoporosis patient-derived BMSCs via high-throughput transcriptome sequencing in combination with bioinformatics analysis. As a result, 415 mRNAs, 30 lncRNAs, 6 circRNAs and 27 miRNAs were found to be significantly changed in the senile osteoporosis group. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were applied to analyze the function of differentially expressed mRNAs and ncRNAs. The circRNA-miRNA-mRNA regulatory network was constructed using the cytoHubba plugin based on the Cytoscape software. Interestingly, circRNA008876-miR-150-5p-mRNA was the sole predicted circRNA-miRNA-mRNA network. The differential expression profile of this ceRNA network was further verified by qRT-PCR. The biological function of this network was validated by overexpression and knockdown experiments. In conclusion, circRNA008876-miR-150-5p-mRNA could be an important ceRNA network involved in senile osteoporosis, which provides potential biomarkers and therapeutic targets for senile osteoporosis.

Citing Articles

mir-150-5p inhibits the osteogenic differentiation of bone marrow-derived mesenchymal stem cells by targeting irisin to regulate the p38/MAPK signaling pathway.

Qi J, Zhang Z, Dong Z, Shan T, Yin Z J Orthop Surg Res. 2024; 19(1):190.

PMID: 38500202 PMC: 10949585. DOI: 10.1186/s13018-024-04671-6.


What happens to the osteoporotic bone mesenchymal stem cells? Evidence from RNA sequencing.

Li M, Cong R, Wang H, Ma C, Lv Y, Zheng Y Int J Med Sci. 2024; 21(1):95-106.

PMID: 38164361 PMC: 10750345. DOI: 10.7150/ijms.88146.


Regulatory mechanisms of circular RNAs during human mesenchymal stem cell osteogenic differentiation.

Mazziotta C, Badiale G, Cervellera C, Tognon M, Martini F, Rotondo J Theranostics. 2024; 14(1):143-158.

PMID: 38164139 PMC: 10750202. DOI: 10.7150/thno.89066.


MSdb: An integrated expression atlas of human musculoskeletal system.

Tian R, Xue Z, Ruan D, Chen P, Xu Y, Dai C iScience. 2023; 26(6):106933.

PMID: 37378342 PMC: 10291471. DOI: 10.1016/j.isci.2023.106933.


Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis.

Yu W, Xie Z, Li J, Lin J, Su Z, Che Y Bone Res. 2023; 11(1):30.

PMID: 37280207 PMC: 10244438. DOI: 10.1038/s41413-023-00267-8.


References
1.
Schwarzer A, Emmrich S, Schmidt F, Beck D, Ng M, Reimer C . The non-coding RNA landscape of human hematopoiesis and leukemia. Nat Commun. 2017; 8(1):218. PMC: 5550424. DOI: 10.1038/s41467-017-00212-4. View

2.
Tang J, Lin X, Zhong J, Xu F, Wu F, Liao X . miR‑124 regulates the osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by targeting Sp7. Mol Med Rep. 2019; 19(5):3807-3814. DOI: 10.3892/mmr.2019.10054. View

3.
Zhao K, Zhao Q, Guo Z, Chen Z, Hu Y, Su J . Hsa_Circ_0001275: A Potential Novel Diagnostic Biomarker for Postmenopausal Osteoporosis. Cell Physiol Biochem. 2018; 46(6):2508-2516. DOI: 10.1159/000489657. View

4.
Lu X, Han W, Liu Y . Suppression of miR-451a accelerates osteogenic differentiation and inhibits bone loss via Bmp6 signaling during osteoporosis. Biomed Pharmacother. 2019; 120:109378. DOI: 10.1016/j.biopha.2019.109378. View

5.
Si W, Kang Q, Luu H, Park J, Luo Q, Song W . CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol. 2006; 26(8):2955-64. PMC: 1446962. DOI: 10.1128/MCB.26.8.2955-2964.2006. View